Abstract
Drugs may decrease serum lipid levels by impairing lipid absorption, lipoprotein synthesis or release, or by stimulating lipid or lipoprotein catabolism (45). Recent data point out, however, that agents such as Clofibrate (CPIB), generally thought to act only by inhibiting lipid and lipoprotein synthesis and release (3), may also affect lipid absorption.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
